-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Stem cell scientists have revealed the origin of a common ovarian cancer by establishing a fallopian tube tissue model, allowing them to describe how genetic mutations put women at a high risk of this cancer
In the United States, ovarian cancer is the leading cause of death from gynecological cancer.
Faced with such a huge chance, some women with BRCA-1 gene mutations choose to have their breasts, ovaries and fallopian tubes removed by surgery, although they may never develop cancer in these tissues
Dr.
Svensson is a professor of biomedical sciences and medicine, and one of the corresponding authors of this new study in Cedars-Sinai
To achieve this discovery, the research team created induced pluripotent stem cells (IPSCs) that can produce any type of cell
Dr.
Svensson said that in addition to showing how the fallopian tubes of women with breast cancer susceptibility gene (BRCA-1) mutations "bred" ovarian cancer, this organoid technique may also be used to determine whether drugs work on individuals
"This research represents an exciting application of IPSCs, bringing us closer than ever to significantly improving outcomes for women with this common ovarian cancer," said Jeffrey Golden, MD, a research and graduate student Deputy Director of Education and Director of Cedars-Sinai Burns and Allen Institute
Article title
Human ipsc-derived fallopian tube organoids Overview of early carcinogenesis in BRCA1 mutation carriers
